Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Revenue

Cell Bio Human Tech Co.,Ltd had revenue of 12.75B KRW in the quarter ending March 31, 2026, with 53.80% growth. This brings the company's revenue in the last twelve months to 55.53B, up 80.57% year-over-year. In the year 2025, Cell Bio Human Tech Co.,Ltd had annual revenue of 51.07B with 79.69% growth.

• Revenue (ttm): 55.53B
• Revenue Growth: +80.57%
• P/S Ratio: 0.76
• Revenue / Employee: 740.34M
• Employees: 75
• Market Cap: 42.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	51.07B	22.65B	79.69%
Dec 31, 2024	28.42B	1.09B	4.01%
Dec 31, 2023	27.32B	-220.33M	-0.80%
Dec 31, 2022	27.54B	-7.62B	-21.66%
Dec 31, 2021	35.16B	6.57B	22.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error